FUSN
Geode Capital Management’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-41,907
| Closed | -$893K | – | 4656 |
|
|
2024
Q1 | $893K | Buy |
41,907
+2,561
| +7% | +$54.6K | ﹤0.01% | 3407 |
|
|
2023
Q4 | $378K | Buy |
39,346
+8,478
| +27% | +$81.5K | ﹤0.01% | 3718 |
|
|
2023
Q3 | $80.3K | Buy |
30,868
+494
| +2% | +$1.28K | ﹤0.01% | 4314 |
|
|
2023
Q2 | $142K | Buy |
30,374
+5,238
| +21% | +$24.5K | ﹤0.01% | 4201 |
|
|
2023
Q1 | $94.8K | Hold |
25,136
| – | – | ﹤0.01% | 4354 |
|
|
2022
Q4 | $79K | Hold |
25,136
| – | – | ﹤0.01% | 4476 |
|
|
2022
Q3 | $75K | Hold |
25,136
| – | – | ﹤0.01% | 4678 |
|
|
2022
Q2 | $62K | Hold |
25,136
| – | – | ﹤0.01% | 4729 |
|
|
2022
Q1 | $195K | Hold |
25,136
| – | – | ﹤0.01% | 4398 |
|
|
2021
Q4 | $104K | Hold |
25,136
| – | – | ﹤0.01% | 4721 |
|
|
2021
Q3 | $199K | Buy |
25,136
+2,047
| +9% | +$16.2K | ﹤0.01% | 4451 |
|
|
2021
Q2 | $186K | Hold |
23,089
| – | – | ﹤0.01% | 4365 |
|
|
2021
Q1 | $247K | Hold |
23,089
| – | – | ﹤0.01% | 4052 |
|
|
2020
Q4 | $271K | Hold |
23,089
| – | – | ﹤0.01% | 3794 |
|
|
2020
Q3 | $277K | Buy |
+23,089
| New | +$277K | ﹤0.01% | 3616 |
|